The expression levels of ASIC2 and ASIC3, widely used biomarkers for extracellular acidosis in our transcripts, are significantly higher in AD and MCI samples than in the normal samples, which are bot-detectable in the existing data (Figure 4D). This evidence concerns the gene ASIC3 and Alzheimer disease.